Lincoln Alternative Strategies LLC's Ownership in Silexion Therapeutics Corp.

Lincoln Alternative Strategies LLC has filed a Schedule 13G with the SEC, disclosing its ownership of 131,250 ordinary shares of Silexion Therapeutics Corp., representing 6.18% of the total outstanding shares. The filing indicates that Lincoln Alternative Strategies LLC has sole voting and dispositive power over these shares. The shares were not acquired for the purpose of influencing the control of the issuer. The filing was made under Rule 13d-1(c) and includes a certification that the shares were not acquired to influence control or as part of a transaction with that purpose.